Principal Financial Group Inc Meridian Bioscience Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$31.15 - $33.39 $227,706 - $244,080	-7,310 Reduced 2.56%	277,881 $9.23 Million
Q3 2022 Nov 09, 2022	SELL	$30.9 - $33.55 $784,458 - $851,733	-25,387 Reduced 8.17%	285,191 $8.99 Million
Q2 2022 Aug 10, 2022	SELL	$23.75 - $31.69 $926 - $1,235	-39 Reduced 0.01%	310,578 $9.45 Million
Q1 2022 May 09, 2022	SELL	$19.97 - $26.94 $252,440 - $340,548	-12,641 Reduced 3.91%	310,617 $8.06 Million
Q4 2021 Feb 09, 2022	SELL	$17.46 - $21.61 $561,059 - $694,415	-32,134 Reduced 9.04%	323,258 $6.59 Million
Q3 2021 Nov 09, 2021	SELL	$17.35 - $22.5 $82,117 - $106,492	-4,733 Reduced 1.31%	355,392 $6.84 Million
Q2 2021 Aug 10, 2021	BUY	$18.01 - $28.32 $27,753 - $43,641	1,541 Added 0.43%	360,125 $7.99 Million
Q1 2021 May 10, 2021	BUY	$19.76 - $29.89 $254,311 - $384,684	12,870 Added 3.72%	358,584 $9.41 Million
Q4 2020 Feb 08, 2021	SELL	$15.73 - $21.66 $174,540 - $240,339	-11,096 Reduced 3.11%	345,714 $6.46 Million
Q3 2020 Nov 06, 2020	BUY	$13.54 - $26.41 $136,808 - $266,846	10,104 Added 2.91%	356,810 $6.06 Million
Q2 2020 Aug 05, 2020	BUY	$7.84 - $23.29 $1,113 - $3,307	142 Added 0.04%	346,706 $8.08 Million
Q1 2020 May 12, 2020	SELL	$5.57 - $11.5 $71,780 - $148,200	-12,887 Reduced 3.59%	346,564 $2.91 Million
Q4 2019 Feb 05, 2020	BUY	$7.9 - $10.14 $4,115 - $5,282	521 Added 0.15%	359,451 $3.51 Million
Q3 2019 Nov 13, 2019	SELL	$9.17 - $12.01 $28,601 - $37,459	-3,119 Reduced 0.86%	358,930 $3.41 Million
Q2 2019 Aug 12, 2019	BUY	$10.88 - $17.6 $62,636 - $101,323	5,757 Added 1.62%	362,049 $4.3 Million
Q1 2019 May 10, 2019	SELL	$15.51 - $17.61 $44,715 - $50,769	-2,883 Reduced 0.8%	356,292 $6.27 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $1,408 - $1,912	-97 Reduced 0.03%	359,175 $6.24 Million
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $187,199 - $206,108	12,606 Added 3.64%	359,272 $5.35 Million
Q2 2018 Aug 13, 2018	BUY	$13.8 - $16.8 $88,954 - $108,292	6,446 Added 1.89%	346,666 $0
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $136,081 - $159,748	9,861 Added 2.98%	340,220 $4.83 Million
Q4 2017 Feb 13, 2018	SELL	$13.55 - $15.8 $18,942 - $22,088	-1,398 Reduced 0.42%	330,359 $4.63 Million
Q3 2017 Nov 02, 2017	BUY	$13.45 - $14.35 $4.46 Million - $4.76 Million	331,757	331,757 $4.74 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account